Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?

Detalhes bibliográficos
Autor(a) principal: Francisqueti-Ferron, Fabiane Valentini [UNESP]
Data de Publicação: 2021
Outros Autores: Garcia, Jéssica Leite [UNESP], Ferron, Artur Junio Togneri [UNESP], Nakandakare-Maia, Erika Tiemi [UNESP], Gregolin, Cristina Schmitt [UNESP], Silva, Janaina Paixão das Chagas [UNESP], dos Santos, Klinsmann Carolo [UNESP], Lo, Ângelo Thompson Colombo [UNESP], Siqueira, Juliana Silva [UNESP], de Mattei, Letícia [UNESP], de Paula, Bruno Henrique [UNESP], Sarzi, Felipe, Silva, Carol Cristina Vágula de Almeida [UNESP], Moreto, Fernando [UNESP], Costa, Mariane Róvero [UNESP], Ferreira, Ana Lucia A. [UNESP], Minatel, Igor Otávio [UNESP], Corrêa, Camila Renata [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.mce.2020.111095
http://hdl.handle.net/11449/205568
Resumo: The literature has reported a higher prevalence of negative clinical outcomes due to Coronavirus disease 19 (COVID-19) in obese individuals. This can be explained by the cytokine storm, result from the cytokine production from both obesity and viral infection. Gamma-oryzanol (γOz) is a compound with anti-inflammatory and antioxidant activities. However, little is known about the γOz action as a possible agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ). The aim of this study was to test the hypothesis that γOz attenuates the cytokine storm by stimulating PPAR-γ in the adipose tissue. Methods: Male Wistar rats were randomly divided into three experimental groups and fed ad libitum for 30 weeks with control diet (C, n = 6), high sugar-fat diet (HSF, n = 6) or high sugar-fat diet + γOz (HSF + γOz, n = 6). HSF groups also received water + sucrose (25%). The γOz dose was 0.5% in the chow. Evaluation in animals included caloric intake, body weight, adiposity index, plasma triglycerides, and HOMA-IR. In adipose tissue was evaluated: PPAR-γ gene and protein expression, inflammatory and oxidative stress parameters, and histological analysis. Results: Adipose tissue dysfunction was observed in HSF group, which presented remarkable PPAR-γ underexpression and increased levels of cytokines, other inflammatory markers and oxidative stress. The γOz treatment prevented adipose tissue dysfunction and promoted PPAR-γ overexpression. Conclusion: Natural compounds as γOz can be considered a coadjutant therapy to prevent the cytokine storm in COVID-19 patients with obesity conditions.
id UNSP_18fc76c060aa3dff0f53201c098c0979
oai_identifier_str oai:repositorio.unesp.br:11449/205568
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?COVID-19Gamma-oryzanolObesityPPAR-γThe literature has reported a higher prevalence of negative clinical outcomes due to Coronavirus disease 19 (COVID-19) in obese individuals. This can be explained by the cytokine storm, result from the cytokine production from both obesity and viral infection. Gamma-oryzanol (γOz) is a compound with anti-inflammatory and antioxidant activities. However, little is known about the γOz action as a possible agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ). The aim of this study was to test the hypothesis that γOz attenuates the cytokine storm by stimulating PPAR-γ in the adipose tissue. Methods: Male Wistar rats were randomly divided into three experimental groups and fed ad libitum for 30 weeks with control diet (C, n = 6), high sugar-fat diet (HSF, n = 6) or high sugar-fat diet + γOz (HSF + γOz, n = 6). HSF groups also received water + sucrose (25%). The γOz dose was 0.5% in the chow. Evaluation in animals included caloric intake, body weight, adiposity index, plasma triglycerides, and HOMA-IR. In adipose tissue was evaluated: PPAR-γ gene and protein expression, inflammatory and oxidative stress parameters, and histological analysis. Results: Adipose tissue dysfunction was observed in HSF group, which presented remarkable PPAR-γ underexpression and increased levels of cytokines, other inflammatory markers and oxidative stress. The γOz treatment prevented adipose tissue dysfunction and promoted PPAR-γ overexpression. Conclusion: Natural compounds as γOz can be considered a coadjutant therapy to prevent the cytokine storm in COVID-19 patients with obesity conditions.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)São Paulo State University (Unesp) Medical SchoolSão Paulo State University (Unesp) Institute of BioscienceBotucatu Integrated College (UNIFAC)São Paulo State University (Unesp) Medical SchoolSão Paulo State University (Unesp) Institute of BioscienceFAPESP: #2015/10626-0FAPESP: #2018/15294-3Universidade Estadual Paulista (Unesp)Botucatu Integrated College (UNIFAC)Francisqueti-Ferron, Fabiane Valentini [UNESP]Garcia, Jéssica Leite [UNESP]Ferron, Artur Junio Togneri [UNESP]Nakandakare-Maia, Erika Tiemi [UNESP]Gregolin, Cristina Schmitt [UNESP]Silva, Janaina Paixão das Chagas [UNESP]dos Santos, Klinsmann Carolo [UNESP]Lo, Ângelo Thompson Colombo [UNESP]Siqueira, Juliana Silva [UNESP]de Mattei, Letícia [UNESP]de Paula, Bruno Henrique [UNESP]Sarzi, FelipeSilva, Carol Cristina Vágula de Almeida [UNESP]Moreto, Fernando [UNESP]Costa, Mariane Róvero [UNESP]Ferreira, Ana Lucia A. [UNESP]Minatel, Igor Otávio [UNESP]Corrêa, Camila Renata [UNESP]2021-06-25T10:17:38Z2021-06-25T10:17:38Z2021-01-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.mce.2020.111095Molecular and Cellular Endocrinology, v. 520.1872-80570303-7207http://hdl.handle.net/11449/20556810.1016/j.mce.2020.1110952-s2.0-85097235316Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengMolecular and Cellular Endocrinologyinfo:eu-repo/semantics/openAccess2021-10-23T14:54:10Zoai:repositorio.unesp.br:11449/205568Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462021-10-23T14:54:10Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
title Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
spellingShingle Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
Francisqueti-Ferron, Fabiane Valentini [UNESP]
COVID-19
Gamma-oryzanol
Obesity
PPAR-γ
title_short Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
title_full Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
title_fullStr Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
title_full_unstemmed Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
title_sort Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
author Francisqueti-Ferron, Fabiane Valentini [UNESP]
author_facet Francisqueti-Ferron, Fabiane Valentini [UNESP]
Garcia, Jéssica Leite [UNESP]
Ferron, Artur Junio Togneri [UNESP]
Nakandakare-Maia, Erika Tiemi [UNESP]
Gregolin, Cristina Schmitt [UNESP]
Silva, Janaina Paixão das Chagas [UNESP]
dos Santos, Klinsmann Carolo [UNESP]
Lo, Ângelo Thompson Colombo [UNESP]
Siqueira, Juliana Silva [UNESP]
de Mattei, Letícia [UNESP]
de Paula, Bruno Henrique [UNESP]
Sarzi, Felipe
Silva, Carol Cristina Vágula de Almeida [UNESP]
Moreto, Fernando [UNESP]
Costa, Mariane Róvero [UNESP]
Ferreira, Ana Lucia A. [UNESP]
Minatel, Igor Otávio [UNESP]
Corrêa, Camila Renata [UNESP]
author_role author
author2 Garcia, Jéssica Leite [UNESP]
Ferron, Artur Junio Togneri [UNESP]
Nakandakare-Maia, Erika Tiemi [UNESP]
Gregolin, Cristina Schmitt [UNESP]
Silva, Janaina Paixão das Chagas [UNESP]
dos Santos, Klinsmann Carolo [UNESP]
Lo, Ângelo Thompson Colombo [UNESP]
Siqueira, Juliana Silva [UNESP]
de Mattei, Letícia [UNESP]
de Paula, Bruno Henrique [UNESP]
Sarzi, Felipe
Silva, Carol Cristina Vágula de Almeida [UNESP]
Moreto, Fernando [UNESP]
Costa, Mariane Róvero [UNESP]
Ferreira, Ana Lucia A. [UNESP]
Minatel, Igor Otávio [UNESP]
Corrêa, Camila Renata [UNESP]
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Botucatu Integrated College (UNIFAC)
dc.contributor.author.fl_str_mv Francisqueti-Ferron, Fabiane Valentini [UNESP]
Garcia, Jéssica Leite [UNESP]
Ferron, Artur Junio Togneri [UNESP]
Nakandakare-Maia, Erika Tiemi [UNESP]
Gregolin, Cristina Schmitt [UNESP]
Silva, Janaina Paixão das Chagas [UNESP]
dos Santos, Klinsmann Carolo [UNESP]
Lo, Ângelo Thompson Colombo [UNESP]
Siqueira, Juliana Silva [UNESP]
de Mattei, Letícia [UNESP]
de Paula, Bruno Henrique [UNESP]
Sarzi, Felipe
Silva, Carol Cristina Vágula de Almeida [UNESP]
Moreto, Fernando [UNESP]
Costa, Mariane Róvero [UNESP]
Ferreira, Ana Lucia A. [UNESP]
Minatel, Igor Otávio [UNESP]
Corrêa, Camila Renata [UNESP]
dc.subject.por.fl_str_mv COVID-19
Gamma-oryzanol
Obesity
PPAR-γ
topic COVID-19
Gamma-oryzanol
Obesity
PPAR-γ
description The literature has reported a higher prevalence of negative clinical outcomes due to Coronavirus disease 19 (COVID-19) in obese individuals. This can be explained by the cytokine storm, result from the cytokine production from both obesity and viral infection. Gamma-oryzanol (γOz) is a compound with anti-inflammatory and antioxidant activities. However, little is known about the γOz action as a possible agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ). The aim of this study was to test the hypothesis that γOz attenuates the cytokine storm by stimulating PPAR-γ in the adipose tissue. Methods: Male Wistar rats were randomly divided into three experimental groups and fed ad libitum for 30 weeks with control diet (C, n = 6), high sugar-fat diet (HSF, n = 6) or high sugar-fat diet + γOz (HSF + γOz, n = 6). HSF groups also received water + sucrose (25%). The γOz dose was 0.5% in the chow. Evaluation in animals included caloric intake, body weight, adiposity index, plasma triglycerides, and HOMA-IR. In adipose tissue was evaluated: PPAR-γ gene and protein expression, inflammatory and oxidative stress parameters, and histological analysis. Results: Adipose tissue dysfunction was observed in HSF group, which presented remarkable PPAR-γ underexpression and increased levels of cytokines, other inflammatory markers and oxidative stress. The γOz treatment prevented adipose tissue dysfunction and promoted PPAR-γ overexpression. Conclusion: Natural compounds as γOz can be considered a coadjutant therapy to prevent the cytokine storm in COVID-19 patients with obesity conditions.
publishDate 2021
dc.date.none.fl_str_mv 2021-06-25T10:17:38Z
2021-06-25T10:17:38Z
2021-01-15
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.mce.2020.111095
Molecular and Cellular Endocrinology, v. 520.
1872-8057
0303-7207
http://hdl.handle.net/11449/205568
10.1016/j.mce.2020.111095
2-s2.0-85097235316
url http://dx.doi.org/10.1016/j.mce.2020.111095
http://hdl.handle.net/11449/205568
identifier_str_mv Molecular and Cellular Endocrinology, v. 520.
1872-8057
0303-7207
10.1016/j.mce.2020.111095
2-s2.0-85097235316
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Molecular and Cellular Endocrinology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799965532656500736